SCHEMBL6004833

SCHEMBL6004833

CSc1c(F)cc(F)cc1-c1ccc2cc(OS(C)(=O)=O)ccc2c1C(=O)c1ccc(OCCC2CCCCN2)cc1

nearest known ligand 0.39

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CHEK2 O96017 1/20 0.39
SSTR2 P30874 7/20 0.35
ENPP3 O14638 4/20 0.33
ENPP1 P22413 1/20 0.32
AURKB Q96GD4 1/20 0.32
LTA4H P09960 1/20 0.31
HTR1A P08908 1/20 0.31
DRD2 P14416 1/20 0.31
HTR1D P28221 1/20 0.31
HTR1B P28222 1/20 0.31
DRD3 P35462 1/20 0.31
ESR1 P03372 2/20 0.31
ESR2 Q92731 2/20 0.31
HRH4 Q9H3N8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6004786 0.90 CHEK2 (0.41) CHEK2SSTR2ENPP3ENPP1AURKB
SCHEMBL6004662 0.89 CHEK2 (0.39) CHEK2SSTR2ENPP3ENPP1AURKB
SCHEMBL6004570 0.86 CHEK2 (0.33) CHEK2SSTR2LTA4HESR1ESR2
SCHEMBL6203665 0.85 CHEK2 (0.40) CHEK2SSTR2ENPP3ENPP1AURKB
SCHEMBL6203386 0.84 CHEK2 (0.39) CHEK2SSTR2ENPP3ENPP1AURKB
SCHEMBL1358938 0.84 ENPP3 (0.47) ENPP3ENPP1ESR1ESR2
SCHEMBL6204827 0.84 CHEK2 (0.39) CHEK2SSTR2ENPP3ENPP1AURKB
SCHEMBL6005515 0.82 CHEK2 (0.42) CHEK2SSTR2AURKBLTA4HESR1
SCHEMBL6003358 0.81 CHEK2 (0.43) CHEK2SSTR2AURKBLTA4HESR1
SCHEMBL6003394 0.81 CHEK2 (0.43) CHEK2SSTR2AURKBLTA4HESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1709021-A1 SELECTIVE ESTROGEN RECEPTOR MODULATORS FOR THE TREATMENT OF VASOMOTOR SYMPTOMS ELI LILLY AND COMPANY (US) 2006-10-11 EP disclosed
WO-2005073204-A1 SELECTIVE ESTROGEN RECEPTOR MODULATORS FOR THE TREATMENT OF VASOMOTOR SYMPTOMS ELI LILLY AND COMPANY (US) 2005-08-11 WO disclosed